stockrowHims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.
- Revenue
- +38.3%
- EPS
- −294.7%
- Free cash flow
- +5.09%
- Total debt
- +40.8%
Quarter to June 2026, against a year earlier
Follow HIMS
Alert me
Hims & Hers Health, Inc. (HIMS) Return on assets
Hims & Hers Health, Inc.'s return on assets over the twelve months to 30 June 2026 was −5.16%, down 14.1 percentage points from fiscal 2025 (8.97%). Over the past ten years it has ranged from −70.4% (fiscal 2019) to 21.9% (fiscal 2024); the current reading is higher than 92% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of −1.67% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 8.97% | (12.97) |
| FY2024 | 21.9% | 27.77 |
| FY2023 | −5.83% | 10.86 |
| FY2022 | −16.7% | (16.69) |
| FY2022 | 0.00% | 39.93 |
| FY2021 | −39.9% | (39.93) |
| FY2021 | 0.00% | 11.20 |
| FY2020 | −11.2% | (11.20) |
| FY2020 | 0.00% | 70.39 |
| FY2019 | −70.4% | (70.39) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| LQDA Liquidia Corporation compare | 35.6% |
| SUPN Indivior Pharmaceuticals Inc. compare | 32.8% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 12.9% |
| LNTH Lantheus Holdings, Inc. compare | 11.4% |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.44% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 3.01% |
| ALKS Alkermes plc compare | −0.01% |
| HIMS Hims & Hers Health, Inc. | −5.16% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −66.3% |
| Drug Manufacturers Specialty & Generic industry median | −1.67% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on HIMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement